Citation Impact
Citing Papers
MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness
1979 StandoutNobel
IMF-κB and Rel: Participants in a Multiform Transcriptional Regulatory System
1993
The inducible transcription activator NF-κB: regulation by distinct protein subunits
1991
The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens
1987 StandoutNature
LMP2+ proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytes
1995
Nuclear RNA export
1998 StandoutNobel
Structure of the human class I histocompatibility antigen, HLA-A2
1987 StandoutNature
Stereochemical basis of DNA recognition by Zn fingers
1994
Functional sites of human class I MHC molecules: Paradigms a dozen?
1987
Cell Biology of Antigen Processing and Presentation to Major Histocompatibility Complex Class I Molecule-Restricted T Lymphocytes
1992
Missing Pieces in the NF-κB Puzzle
2002 Standout
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
1995 StandoutNatureNobel
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.
1996 StandoutNobel
Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
1995 StandoutNobel
The conformational flexibility of class I H-2 molecules as revealed by anti-peptide antibodies specific for intracytoplasmic determinants: Differential reactivity of β2-microglobulin “bound” and “free” H-2Kb heavy chains
1990
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Structure of 20S proteasome from yeast at 2.4Å resolution
1997 StandoutNatureNobel
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Compilation of vertebrate-encoded transcription factors
1992
Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
1994 Standout
T cell receptor antagonist peptides induce positive selection
1994 Standout
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB
1994 Standout
HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.
1995 StandoutNobel
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
IMPAIRED H‐2 EXPRESSION IN B 16 MELANOMA VARIANTS
1983
Binding of a nuclear factor to a regulatory sequence in the promoter of the mouse H-2Kb class I major histocompatibility gene.
1987
Adenovirus E1A-mediated regulation of class I MHC expression.
1986
Immunological Surveillance of Tumors in the Context of Major Histocompatibility Complex Restriction of T Cell Function
1984 StandoutNobel
The mouse T cell receptor: Structural heterogeneity of molecules of normal T cells defined by Xenoantiserum
1983 StandoutNobel
Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
1992 StandoutNobel
Reversal of Oncogenesis by the Expression of a Major Histocompatibility Complex Class I Gene
1985 Science
Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B.
1996 Standout
AIDS virus env Protein Expressed from a Recombinant Vaccinia Virus
1986 StandoutNobel
Primary Biliary Cirrhosis
1987 Standout
Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter.
1989 StandoutNobel
The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family
1985 StandoutNobel
Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis
1995 StandoutScience
Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.
1985
Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfection
1985 Nature
A Role for Nucleoporin FG Repeat Domains in Export of Human Immunodeficiency Virus Type 1 Rev Protein and RNA from the Nucleus
1996 StandoutNobel
Cancer Metastasis: Experimental Approaches, Theoretical Concepts, and Impacts for Treatment Strategies
1985
The Galvanization of Biology: A Growing Appreciation for the Roles of Zinc
1996 StandoutScience
Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells.
1991 StandoutNobel
The major histocompatibility complex class I heavy chain as a structural subunit of the human cell membrane insulin receptor: implications for the range of biological functions of histocompatibility antigens.
1986
Structural and functional dissection of an MHC class I antigen-binding adenovirus glycoprotein.
1986 StandoutNobel
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation
1984 Nature
Complex formation of class I transplantation antigens and a viral glycoprotein.
1983 StandoutNobel
Role of CD47 as a Marker of Self on Red Blood Cells
2000 StandoutScience
Structure of Class I Major Histocompatibility Antigens
1983
Transcription of the E2F-1 Gene Is Rendered Cell Cycle Dependent by E2F DNA-Binding Sites within Its Promoter
1994 StandoutNobel
Insect immunity: developmental and inducible activity of the Drosophila diptericin promoter.
1992 StandoutNobel
Serum β2-microglobulin binds to a T-cell differentiation antigen and increases its expression
1984 StandoutNatureNobel
Apparent alteration in MHC antigens in K36.16, an AKR thymoma, does not result in genetic rearrangement.
1983
Functional expression of a microinjected Edα gene in C57BL/6 transgenic mice
1985 StandoutNatureNobel
Functional analysis and regulation of nuclear import of dorsal during the immune response in Drosophila.
1995 StandoutNobel
Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens.
1986 StandoutNobel
Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation.
1993
Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance
2002 StandoutNobel
Normal Development of Mice Deficient in β 2 M, MCClass I Proteins, and CD8 + T Cells
1990 StandoutScienceNobel
Binding of a Nuclear Factor to a Regulatory Sequence in the Promoter of the Mouse H-2Kb Class I Major Histocompatibility Gene
1987
Tumor induction by simian virus 40 in mice is controlled by long-term persistence of the viral genome and the immune response of the host
1984
Differential expression of H–2 gene products in tumour cells is associated with their metastatogenic properties
1980 Nature
Hepatitis C Virus Envelope Glycoprotein E1 Originates in the Endoplasmic Reticulum and Requires Cytoplasmic Processing for Presentation by Class I MHC Molecules
1999 StandoutNobel
A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum
1987 StandoutNobel
Disulfide cross-linking in crude embryonic lysates reveals three complexes of the Drosophila morphogen dorsal and its inhibitor cactus.
1994 StandoutNobel
Characterization of “H‐2K,D‐like structures” on MM2 × mouse L cell hybrids. II. An “H‐2Kd‐like” structure on C3H‐derived tumor
1983
Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
1985 Standout
Expression of marine H–2Kb histocompatibility antigen in cells transformed with cloned H–2 genes
1982 Nature
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
1986 StandoutNature
KBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells.
1993
Three-dimensional structure of beta 2-microglobulin.
1985
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
1986 StandoutNature
Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B.
1996 StandoutNobel
The In Vitro Generation of Effector Lymphocytes and Their Employment in Tumor Immunotherapy
1983
Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells
1983 Nature
Secondary, tertiary, and quaternary structure of T-cell-specific immunoglobulin-like polypeptide chains.
1986 StandoutNobel
The Role of β 2 -Microglobulin in Peptide Binding by Class I Molecules
1990 Science
MHC imbalance and metastatic spread in Lewis lung carcinoma clones
1983
Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.
1989 Standout
The functional domains of the Drosophila morphogen dorsal: evidence from the analysis of mutants.
1992 StandoutNobel
Works of Wilhelm Schmidt being referenced
Monoclonal antibodies recognize interaction determinants of MHC plus foreign beta-2 microglobulin
1988
ORGANIZATION OF THE AKR Qa REGION: STRUCTURE OF A DIVERGENT CLASS I SEQUENCE, Q5k
1989
Variation in MHC Antigenic Profiles of Tumor Cells and its Biological Effects
1981
Differential regulation of H-2 antigen expression in tumors and its biologic consequences.
1981
Interspecies exchange of β 2-microglobulin and associated MHC and differentiation antigens
1981
Loss of H-2Kk gene product(s) from an AKR spontaneous leukaemia
1979
A Transcription Factor Interacting with the Class I Gene Enhancer Is Inactive in Tumorigenic Cell Lines Which Suppress Major Histocompatibility Complex Class I Genes
1990
A transcription factor interacting with the class I gene enhancer is inactive in tumorigenic cell lines which suppress major histocompatibility complex class I genes.
1990
IMMUNOGENETIC STUDIES ON METH‐A‐VACCINIA TUMOUR CELLS IN VIVO AND IN VITRO*
1977
Variation of expression of histocompatibility antigens on tumor cells: absence of H-2Kk-gene products from a gross-virus-induced leukemia in BALB.K
1981
Resistance to cell-mediated cytotoxicity is correlated with reduction of H-2K gene products in AKR leukemia
1982